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Micro-CTKruppel-like transcription factor 5 (Klf5) was detected in the developing and mature murine bladder urothelium.
Hereinwe report a critical role of KLF5 in the formation and terminal differentiation of the urothelium. The ShhGfpCre
transgene was used to delete the Klf5ﬂoxed alleles from bladder epithelial cells causing prenatal hydronephrosis,
hydroureter, and vesicoureteric reﬂux. The bladder urothelium failed to stratify and did not express terminal
differentiationmarkers characteristic of basal, intermediate, and umbrella cells including keratins 20, 14, and 5, and
theuroplakins. The effects ofKlf5deletionwere unique to the developing bladder epitheliumsincematuration of the
epithelium comprising the bladder neck and urethra was unaffected by the lack of KLF5. mRNA analysis identiﬁed
reductions in Pparγ,Grhl3, Elf3, andOvol1expression inKlf5deﬁcient fetal bladders supporting their participation in a
transcriptional network regulating bladder urothelial differentiation. KLF5 regulated expression of the mGrhl3
promoter in transient transfection assays. The absence of urothelial Klf5 altered epithelial–mesenchymal signaling
leading to the formation of an ectopic alpha smooth muscle actin positive layer of cells subjacent to the epithelium
anda thinner detrusormuscle thatwasnot attributable todisruptionof SHHsignaling, a knownmediator of detrusor
morphogenesis. Deletion of Klf5 from the developing bladder urothelium blocked epithelial cell differentiation,
impaired bladder morphogenesis and function causing hydroureter and hydronephrosis at birth.ital Medical Center, Division of
, Cincinnati, OH 45229, USA.
itsett).
tion, and Immunity, School of
st Clinical Research Facility &
iversity Hospital Trust, UK.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Congenital disorders of the kidney and urinary tract include renal
dysplasia, hydroureter, vesicoureteric reﬂux (VUR), and bladder
outlet obstruction (Kerecuk et al., 2008). VUR involves the retrograde
ﬂow of urine from the bladder to the kidneys, placing affected
individuals at risk for upper urinary tract infections leading to renal
scarring and ultimately renal failure. VUR presents in 1–2% of all
children and ~8% of patients with VUR develop end-stage renal failure
(Kerecuk et al., 2008; Murer et al., 2007). The embryological origin of
VUR has been attributed to several different mechanisms. In humans
and mice, Pax2 heterozygosity delays the disassociation of the ureter
from the Wolfﬁan duct resulting in a shortened intravesicle ureter
with an aberrant angle of entry into the bladder causing VUR(Murawski et al., 2007). Incorrectly positioned distal ureters resulting
in ureteric obstruction, hydronephrosis, and megaureters are ob-
served in Rar α, β double mutants and Ret−/− animals (Mendelsohn
et al., 1994; Srinivas et al., 1999). In contrast, over expression of Ret
results in malformed kidneys and VUR (Yu et al., 2004). VUR also
occurs in humans and mice with duplicate ureters due to inappro-
priate positioning of the ureters into the bladder wall (Murawski and
Gupta, 2008; Murer et al., 2007). A delay in the timing of ureteric bud
outgrowth and distal ureter contact with the UGS is observed in mice
in the absence of Lim1 resulting in VUR, renal hypoplasia, and dilated
ureters (Pedersen et al., 2005). Animals deﬁcient in either uroplakin
3a (Upk3a) or UpkII exhibit VUR and hydronephrosis indicating that a
lack of normal cytoskeletal organization within urothelial cells can
contribute to VUR (Hu et al., 2000; Kong et al., 2004).
Although derived from different embryological lineages, the
epithelium lining in both the ureters and bladder differentiates into
a stratiﬁed urothelium with well deﬁned morphological and cellular
characteristics. The mature urothelium consists of three distinct cell
layers: basal, intermediate and superﬁcial. Cell proliferation is highest
in the basal cell layer and is sometimes observed in the intermediate
cells (Ayres et al., 1985). The superﬁcial cells, also termed umbrella
cells, are highly adapted to maintain a permeability barrier between
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dynamically with the cycles of contraction and distension of the
bladder as it empties and ﬁlls. These functions involve a unique apical
membrane specialization of the umbrella cells that produces an
asymmetrical unit membrane comprised of integral membrane
proteins belonging to the uroplakin (Upk) gene family (Wu et al.,
2009). With the exception of Upk3b, Upks are expressed exclusively in
urothelial cells during advanced stages of differentiation. The
paracellular barrier of the urothelium is mediated by differential
expression of tight junction proteins including the claudins (Cldn).
The expression and localization of several CLDN family members have
been associated with speciﬁc urothelial cell types and stages of
urothelial maturation (Acharya et al., 2004; Varley et al., 2006).
Urothelial maturation also involves alterations in cytokeratin (Krt)
gene expression (Baskin et al., 1996). The expression of Krts 5 and 14
is initiated and co-localized with Krts 7 and 19 in basal and
intermediate cells (Smith et al., 2002). Fully differentiated umbrella
cells uniquely express Krt 20 (Erman et al., 2006). Although the
morphology and cell types comprising the bladder urothelium are
well characterized, little is known of the transcription factors and
pathways that mediate urothelial maturation.
Kruppel-like transcription factor 5 (KLF5) is expressed in highly
proliferative epithelial cell types during embryogenesis and in the
adult including the skin, gut, prostate, lung, mammary gland, and
bladder, as well as in immortalized epithelial cell lines and
proliferating primary cultures (McConnell et al., 2007). Embryonic
stem cell studies indicate an important role for KLF5 in self-renewal
and the maintenance of pluripotency (Nandan and Yang, 2009). We
previously demonstrated that KLF5 is required for terminal matura-
tion of lung epithelial cells (Wan et al., 2008). In the present study, we
demonstrate that KLF5 is required for normal maturation of the
murine bladder urothelium and suggest that Grhl3 and Pparγ are
candidate transcriptional downstream targets that mediate this
process. Deletion of Klf5 from the developing bladder urothelium
causes prenatal VUR, hydroureter, and hydronephrosis.
Materials and methods
Animals
Animal protocols were approved by the Institutional Animal Care
and Use Committee in accordance with NIH guidelines. Animals
harboring the ShhGfpCre allele were purchased from Jackson Labora-
tories (Bar Harbor, ME) and mated with Klf5ﬂox/ﬂox animals. Klf5ﬂox/ﬂox
females were time mated to Klf5ﬂox/+ShhGfpCre males overnight and
the presence of a vaginal plug deﬁned as embryonic day 0.5 (E0.5). For
immunohistochemistry, embryos were ﬁxed in paraformaldehyde
(4%) in PBS and subsequently dehydrated in graded ethanols for
parafﬁn embedding or equilibrated in 30% sucrose prior to embedding
in OCT. Genomic DNA isolated from fetal tails was used for
genotyping.
β-galactosidase staining
For whole mount visualization, dissected urinary tracts were ﬁxed
2 h in 2% PFA, 0.25% gluteraldehyde in PBS, rinsed 3 times in PBS, and
developed for 8 h in 5 mM K3Fe(CN6), 5 mM K4Fe(CN6), 2 mMMgCl2,
0.01% Sodium deoxycholate, 0.2% NP-40, and 1 mg/ml X-Gal. Stained
tissues were equilibrated in sucrose and embedded in OCT prior to
sectioning.
Micro computerized tomography
E18.5 whole fetuses were ﬁxed and stored in 4% paraformaldehyde
in PBS. Forty-eight hours prior to imaging, fetuses were rinsed in PBS
and placed in isotonic 25% Iodine solution as described by Degenhardtet al. (2010). Imageswere obtained using amicroCAT II micro CT using
a kVp of 80 and an anode current of 225 micro-amps. 776 projections
were collected through 194 degrees of gantry rotation using an x-ray
exposure time of 2.30 s and a bin factor of 2. The set of projections was
reconstructed using COBRA (cone beam reconstruction algorithm,
Exxim Computing Corporation, Pleasanton, CA USA). The recon-
structed image voxel size was 19.4 microns isotropic. The raw CT slice
data were loaded in to Amira (Visage Imaging, San Diego, CA USA) for
viewing and conversion to DICOM format that have been viewed and
processed in OsiriX, an open-source image processing software
(Pixmeo, Geneva, Switzerland).
Immunohistochemistry
Parafﬁn embedded tissue was sectioned at 6 μm, dewaxed,
rehydrated in graded ethanols, subjected to antigen retrieval (as
necessary using 0.1 M citrate buffer, pH 6.0, and heat), and
endogenous peroxidase activity was quenched in methanol and
H2O2 for 15 min. Frozen sections were cut at 7 μm, dried overnight
and ﬁxed in 4% PFA for 10 min prior to antigen retrieval and
quenching. Primary antibodies requiring antigen retrieval were
guinea pig anti-KLF5 (in house, 1:1500; Wan et al., 2008), mouse
anti-Keratin14 (Neomarkers LL002, 1:300), rabbit anti-Keratin 5 (in
house, 1:1000), rabbit anti-FOXA1 (Seven Hills Bioreagents, 1:1000),
rabbit anti-SOX2 (Seven Hills Bioreagents, 1:2500), rabbit anti-SOX9
(Millipore, AB5535, 1:800), rabbit anti-PhosphoHistone H3 (Santa-
Cruz, SC8656R, 1:500), rat anti-Ki67 (Dako, TEC-3 clone M7249,
1:1000), p63 (Santa Cruz, SC71827, 1:500), mouse anti-smoothelin
(Millipore, MAB3242, 1:200), chicken anti-Beta Galactosidase
(Abcam, ab9361, 1:3000), rat anti-cyclin D1 (Millipore, 04–1151,
1:1000) and rabbit anti-PAX2 (Invitrogen, 716000, 1:1000). Other
antibodies included rabbit anti-Desmin (Abcam, 152001, 1:400),
mouse anti-α-smooth muscle actin (Sigma, monoclonal 1A4,
1:6,000); goat anti-UPK1B (Santa Cruz, Ni20, 1:100), and anti-
KRT20 (Dako, monoclonal KS20.8 M7019, 1:25). Biotinylated second-
ary antibodies (1:200, Vector Laboratories) were detected using an
avidin-biotin-horseradish-peroxidase detection system (ABC reagent,
Vector Laboratories, Burlingame, CA). Sections were counterstained
with Nuclear Fast Red. As a negative control, primary antibody was
omitted on some slides. At least three animals of each genotype were
evaluated at each time point using the antibodies indicated.
Real-time RT-qPCR
Total RNA was isolated from E14.5 or E16.5 embryonic bladders
dissected free from the ureters and urethra using the QIAGEN microRNA
isolationkit.Klf5wt/wtShhGfpCre+embryoswereused for the control sample.
cDNA was generated using the Versa RT-kit (ThermoScientiﬁc). At least
three independent cDNA sampleswere used per genotype. cDNA samples
were ampliﬁed in triplicate on a StepOne Plus Real Time PCR system
(Applied Biosystems). All values were normalized to ribosomal protein
18 s within the sample and values calculated using the 2-ΔΔCT (Livak)
method. The Applied Biosystems TAQMAN primer pairs used were Klf5
(Mm00456521_m1) , Ppa rγ (Mm01184322_m1) ,Grh l3
(Mm01193339_m1) , p63 (Mm00495788_m1) , Ovo l 1
(Mm00498263_m1), Elf3 (Mm01295975_m1), Shh (Mm00436527_m1),
Ptch1 (Mm00436026_m1), Gli1 (Mm00494645_m1), Gli2
(Mm01293116_m1), and Bmp4 (Mm00432087_m1).
Reﬂux evaluation
The bladders of E18.5 and P0 mice were surgically exposed
following removal of the gastrointestinal tract. Klf5ﬂox/ﬂoxShhGfpCre-,
Klf5ﬂox/wtShhGfpCre-, and Klf5ﬂox/wtShhGfpCre+ littermates were used as
the controls. A 1 cc syringe ﬁlled with India ink was attached to a 30-
gauge needle. The needle was inserted into the bladder lumen and a
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external surface of the bladder wall. Each fetus was evaluated for the
appearance of ink in the ureters, renal pelvi, and evacuation out the
urethra.
Urothelial cell proliferation
Bladders from 4 Klf5Δ/Δ and 4 controls (either Klf5+/+ShhGfpCre+ or
Klf5ﬂox/ﬂoxShhGfpCre-) embryoswere sectioned. Three sections per E16.5
bladder were taken approximately 100 μM apart and stained for
phospho-Histone H3 (pHH3). The entire luminal surface of each
bladder section (except the region containing and distal to the
trigone) was photographed using a 20× objective. The total number of
pHH3 positive cells and the total number of urothelial cells were
determined using MetaMorph software (Molecular Devices; Sunny-
vale, CA). For each embryo, the number of pHH3 positive nuclei and
total nuclei were summed from the three sections to determine the
percentage of pHH3 positive nuclei/bladder. These values were
subjected to a 2-tailed paired Student t-test.
mRNA microarray analysis
Total RNA from E14.5 whole bladders isolated from Klf5Δ/Δ and
Klf5+/+ShhGfpCre+ embryos (n=3 samples/genotype, each sample a
pool of two bladders) was isolated using the Qiagen MicroRNA Kit.
The cDNA was then hybridized according to the manufacturer's
protocol to the Affymetrix Mouse Gene 1.0 ST Array, covering 28,853
genes with approximately 27 probes per gene spread across the full
length of each gene. The RNA quality and quantity assessment, probe
preparation, labeling, hybridization and image scan were carried out
in the CCHMC Affymetrix Core using standard procedures. Hybridi-
zation data were sequentially subjected to normalization, transfor-
mation, ﬁltration, functional classiﬁcation and pathway analysis as
previously described (Xu et al., 2009). Data analysis was performed
with Genespring GX11. All probe sets on the array were pre-ﬁltered
based on their signal intensity such that a probe was kept for further
analysis if the probe signal intensity was N35th percentile in at least 2
of 3 samples. Differentially expressed genes in response to Klf5
deletion vs control mice were identiﬁed using an unpaired Student t-
test. Changes in gene expression were considered statistically
signiﬁcant if their p value was less than 0.05 and fold-change was
greater than 1.5. Gene Ontology Analysis was performed using the
publicly available web-based tool DAVID (database for annotation,
visualization, and integrated discovery)(Huang da et al., 2009). A gene
ontology term is considered to be overly-represented when a Fisher's
exact test P value is ≤0.001 and gene hits are ≥5. The complete
dataset can be accessed from geo@ncbi.nlm.nih.gov by the accession
number GSE27014.
Transient transfection assays
The mGrhl3 promoter was isolated by PCR using the primers 5′-
GCATAAAGAAGGCTTGGCACG-3′ and 5′GGCTGGAAGCACAGGTGCC-
GACTG-3′ to amplify a 1744 bp product which was sequence veriﬁed
and subcloned into pGL4 (Promega) to create GL4mGrhl3Luc. T24
(human bladder epithelial transitional carcinoma, ATCC HTB-4) and
HEK293T (human embryonic kidney epithelia) cells were grown to
40% conﬂuence in six well plates and transfected with plasmid DNA
(0.5 μg) using FuGene 6 (Roche). Promoter activity was determined
by measurement of luciferase activity normalized to β-galactosidase
activity 48 h after transfection. All experimentswere done in triplicate
in 3 independent experiments. Lipofectamine 2000 (Invitrogen) was
used to transfect 100 pmoles of either hKlf5 (Am16708) or control
(Am4611) siRNA (Ambion). Part of each lysate was utilized for
Western Blot analysis. Blots were hybridized with a guinea pig anti-KLF5 antibody (Wan et al., 2008; 1:4000) and rabbit anti-GAPDH
(Abcam, ab9485, 1:5000) as a loading control.Results
Developmental expression of KLF5 in the urinary tract
Immunohistochemical (IHC) analysis revealed that KLF5 was
expressed in the invaginating cloacal epithelium beginning on
E10.5. At E14.5, E16.5, and E18.5, KLF5 was detected in the epithelium
lining the bladder, bladder neck, urethra, ureter and kidney (Figs. 1A–
C, data not shown). In the fetal and adult bladder urotheliumKLF5was
detected in all cell layers (Fig. 1B’), with the lowest levels of
expression in the terminally differentiated umbrella cells.Deletion of Klf5 by ShhGfpCre
To begin to understand the role of KLF5 in maturation of the
bladder urothelium, Klf5ﬂoxed animals were mated with animals
harboring the ShhGfpCre allele in which an EGFPCre-recombinase
fusion cassette was inserted into the start site of the Shh locus
resulting in Cre expression under control of the endogenous Shh
promoter (Harfe et al., 2004; Seifert et al., 2008). Shh expression
begins as early as E10 in the lung and invaginating cloacal epithelium
and is expressed throughout the bladder epithelium until at least
E14.5 (Haraguchi et al., 2007; Harris et al., 2006). KLF5 IHC revealed
an almost complete loss of KLF5 in the bladder, bladder neck, and
urethral epithelium of the urinary tract, as well as the lung
epithelium of E14.5 (n=3), E16.5 (n=5), and E18.5 (n=6)
Klf5ﬂox/ﬂoxShhGfpCre+ (Klf5Δ/Δ) fetuses (Figs. 1D–F, data not shown).
Consistent with our previous studies deleting Klf5 using lung speciﬁc
drivers, all Klf5Δ/Δ fetuses died shortly after birth of respiratory
distress (Wan et al., 2008). Previous reports indicated that Shh is
expressed in the developing ureter and kidney (Yu et al., 2002). KLF5
expressionwasmaintained in the ureter and renal pelvis Klf5Δ/Δmice
(Figs. 1E, 2H, data not shown). ShhGfpCre dependent recombination at
the Rosa26 locus was evaluated by whole mount β-galactosidase
staining of dissected urogenital tracts and/or IHC for β-galactosidase.
Both analyses indicated inefﬁcient levels of recombination within
the ureters with the highest levels of recombination present in the
most proximal third of the ureters (Figs. 1 G–H). Little to no
recombination occurred in the middle and distal regions of the
ureters (Figs. 1G, I). Combined these observations indicate that Klf5 is
not efﬁciently removed from the ureteric epithelium by the ShhGfpCre
allele.Hydroureter, hydronephrosis, and VUR after deletion of Klf5
At E18.5 and P0, the ureters and renal pelvi of all Klf5Δ/Δ fetuses
were dilated. Hydroureter and hydronephrosis were conﬁrmed by
visualization, serial sectioning, and high resolutionmicro-computerized
tomography (CT)(Fig. 2). Differences in size or structure of the kidneys
at E14.5 and E16.5 were not detected by IHC staining for PAX2 or SOX9
(Figs. 2E,F, data not shown). Injection of India ink into thebladder lumen
followed by palpation of the bladder resulted in vesicoureteric reﬂux in
6/6 Klf5Δ/Δ fetuses that occurred bilaterally in 4 of the 6 fetuses (Figs. 2A
vs B). In contrast, of the 10 nonmutants evaluated, only 1 exhibited
reﬂux and it was unilateral. In previous studies, VUR was attributed to
defects in formation of the kidneys and/or ureters (Airik et al., 2006,
2010; Chang et al., 2004; Iizuka-Kogo et al., 2007;Murawski et al., 2007;
Nie et al., 2010). In all Klf5Δ/Δ fetuses a single ureter and kidney were
observed bilaterally, indicating that VUR is not attributable to
duplications of the kidneys and/or ureters.
Fig. 1. KLF5 expression and efﬁciency of recombination of the Klf5ﬂoxed allele by ShhGfpCre during bladder and ureter development. KLF5 immunohistochemistry was performed at the
indicated embryonic time points. (A–C) control embryos. (D–F) Klf5Δ/Δ embryos. Klf5 is efﬁciently deleted throughout the bladder lumen epithelium (arrowheads) and bladder neck
but not from the epithelium of the ureter. B′ and E′ insets are 10×magniﬁcation of the lumen epithelium shown in B and E. Note absence of KLF5 expression and presence of a single
cell layer in E′ vs 3–4 cells comprise the control (B′). Small region between arrowheads in F shows a segment containing KLF5 positive cells that was observed in the bladders of a few
embryos where deletion did not occur. (G) β-galactosidase whole mount staining of an isolated ShhGfpCre+Rosa26+/– urinary tract. Note most staining is restricted to the proximal
ureter with little to no staining in the mid and distal ureter. (H–I) IHC staining of sectioned ureters with anti-β-galactosidase. (H) Proximal region indicated in (G) closest to renal
pelvis exhibits varying β-galactosidase expression. (I) Within the middle segment of the ureter as indicated in (G) only a few scattered cells express β-galactosidase.
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differentiation of the urothelium
The ShhCre transgene was highly active in the bladder urothelium
resulting in efﬁcient early deletion of Klf5 that inhibited maturation of
the bladder urothelium. At E14.5, a single cell layered epithelium lined
the forming bladder in Klf5Δ/Δ embryos, whereas epithelial stratiﬁca-
tion was evident in control embryos (Figs. 1A,D). As urothelial
maturation proceeded, three distinct cell layers: basal, intermediate,
and umbrella were ﬁrst evident in control fetuses at E16.5 (Fig. 1B’)
and persisted at E18.5. As seen at E14.5, a single cell layered
epithelium lined the bladder of E16.5 and E18.5 Klf5Δ/Δ fetuses
(Figs. 1D–F). At E16.5, p63 expression was predominantly localized to
basal cells in control mice and was dramatically reduced or
undetectable (Figs. 3A,A’ vs B,B’) in the single layer of cells lining
the bladder of Klf5Δ/Δ fetuses. Unlike p63, expression of FOXA1
persisted in most cells comprising the single layered epithelium lining
the E16.5 and E18.5 Klf5Δ/Δ bladders while in control mice a gradient
of FOXA1 expression was established with the highest levels of
expression present in the terminally differentiated umbrella cell layer(Figs. 3C,C’,D,D’). At E18.5, umbrella cells within the superﬁcial layer
of control fetuses expressed KRT20 and UPK1B (Figs. 4A,C). KRT14 and
KRT5 were expressed in the basal and intermediate cell layers of the
bladder urothelium (Fig. 4E, data not shown). UPK1B, KRT20, KRT14
or KRT5were not detected in the simple epithelium lining the bladder
of Klf5Δ/Δ fetuses indicating the absence of terminally differentiated
basal and umbrella cells (Figs. 4B,D,F, data not shown).
In contrast, stratiﬁcation of the urothelium of control and Klf5Δ/Δ
ureters was initiated by E16.5 (Figs. 2E, F inserts) although fewer cell
layers were noted in Klf5Δ/Δ fetuses. At E18.5, KLF5 was detected in
most cells lining the ureteric epithelium of Klf5Δ/Δ fetuses (Fig. 2H).
However, the urothelium of control fetuses possessed 2–3 cell layers
whereas only 1–2 cell layers were evident in the dilated ureters of
Klf5Δ/Δ fetuses (Figs. 2G, H). Whether this difference in appearance is
attributable to the dilated state of the ureter or partly to incomplete
recombination of the Klf5ﬂoxed allele within this tissue is not known.
Ureters from Klf5Δ/Δ E18.5 fetuses expressed UPK1B (Figs. 2K,L) and
Keratin 20 (KRT20)(data not shown) indicating that the ureteric
urothelium expresses mature urothelial markers. Alpha smooth
muscle actin (αSMA) was detected in smooth muscle surrounding
Fig. 2. Vesicoureteric reﬂux, hydroureters, and ureteral maturation in Klf5Δ/Δ fetuses. (A-B) India ink injection into bladder lumen followed by palpation. (B) Ink is present in ureters
and renal pelvi. (C–D) Dissected out urinary tracts. Note hydroureter in D vs C (arrows) and opaqueness of bladder in (D). (E–L) Immunohistochemical staining for the indicated
markers. (E–F) Some dilation of the ureter is evident as early as E16.5 in Klf5Δ/Δ fetuses and the ureteric urothelium appears slightly thinner. Insets are higher magniﬁcation of the
indicated region. (G–H) The Klf5Δ/Δ ureteric urothelium expresses KLF5 but is only 1–2 cells thick vs the 2–3 cell layers observed in controls (arrowheads). (I–J) Hydronephrosis and
hydroureter in Klf5 deﬁcient fetuses. Smooth muscle lines the renal pelvis and surrounds the ureter in the Klf5Δ/Δ fetus and in controls (arrows). (K–L) Ureter cross sections, arrows
indicate UPK1B staining on lumenal cells. (A–L) All scale bars represent 10 μm. (M–N)Micro-CT scans of fetuses. (M) Control, (N) Klf5Δ/Δ. A distended bladder, hydronephrosis of the
renal pelvis, and a patent hydroureter (arrowheads) are shown. Kidney (K), Bladder (Bl), Renal pelvis (RP).
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Taken together these data indicate that in contrast to the profound
affect on morphogenesis of the bladder urothelium, the ureteric
urothelium undergoes normal terminal differentiation suggesting
that the observed hydroureters are not attributable to deﬁciencies in
ureter urothelial maturation.Normal maturation of Klf5 deﬁcient bladder neck and urethral
epithelium
The bladder, bladder neck, and urethral epithelium are all derived
from the cloacal epithelium (Seifert et al., 2008). In sharp contrast to
the ﬁndings in the bladder, the absence of KLF5 in the bladder neck
and urethra did not prohibit their normal differentiation. In the
normal bladder, bladder neck and urethral epithelium; KLF5, p63,
FOXA1, KRT14 and KRT5 were expressed by cells within all threecompartments, whereas expression of the uroplakins was restricted
to the bladder urothelium (Figs. 1C, 3A–A”, C–C”, 4E, data not shown)
(Romih et al., 2005). Distinction between the epithelium destined to
form the bladder versus the bladder neck/urethra was demarcated by
E14.5 in both control and Klf5Δ/Δ embryos by regionalized expression
of SOX2 (Figs. 3G,H). Normal expression of p63, FOXA1, KRT14, KRT5,
and cyclin D1 was observed in the bladder neck and urethral
epithelium of Klf5Δ/Δ fetuses (Figs. 3B, B”, D, D”, F4, F, and data not
shown). These observations reveal a critical role of KLF5 in formation
and differentiation of the bladder urothelium but not the adjacent
bladder neck and urethral epithelium.Deletion of Klf5 does not alter urothelial proliferation at E14.5 or E16.5
Phosphohistone H3 (pHH3) and Ki67 stains were similar in control
and Klf5Δ/Δmice at E14.5 and E16.5. At E16.5 the proliferative rate was
Fig. 3. Decreased expression of transcription factors associated with urothelial
maturation in the absence of KLF5. (A-F) Immunohistochemical analysis at E16.5 of
the indicated proteins. (A’–D’) higher magniﬁcation of bladder urothelium. (A”–D”)
higher magniﬁcation of adjacent bladder neck/urethra. The bladder neck/urethra
stratiﬁed normally in Klf5Δ/Δ fetuses, whereas the bladder urothelium remained single
layered. (E–F) Arrows indicate expression of cyclin D1 within the basal cells of the
stratiﬁed bladder neck and urethral epithelium. (G–H) E14.5 embryos. Note
demarcation in SOX2 positive staining at bottom edge of bladder vs bladder neck
region in both control and Klf5Δ/Δ embryos.
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positive cells within the epithelial population of the bladder lumen in
control and Klf5Δ/Δ fetuses. A statistically signiﬁcant difference was
not observed between cellular proliferation in KLF5 deﬁcient (24.07
±4.76 s.e.m.) and control (28.02±4.61 s.e.m.)(p=0.572) bladder
epithelium. In TSU-Pr1 human bladder cancer cells and other tissues,
KLF5 induced cellular proliferation by activating cyclin D1 expression
(Chen et al., 2006; Ema et al., 2008; Nandan et al., 2005; Sun et al.,
2001; Yang et al., 2007). Cyclin D1 stainingwas absent in thematuring
bladder urothelium at E14.5, E15.5 and E16.5 in both control and
Klf5Δ/Δ bladder epithelium (Figs. 3E–F, and data not shown). A few
cells stained positively for cyclin D1 in the bladder epithelium of
controls and Klf5Δ/Δ fetuses at E18.5. In contrast, cyclin D1 was
detected in basal cells of the bladder neck at E16.5 and E18.5 in both
control and Klf5 deﬁcient epithelium. Due to the absence of effects on
epithelial cellular proliferation in the Klf5Δ/Δ bladder epithelium, we
evaluated cell death. Tunnel assay detected few dying cells in E16.5control or Klf5Δ/Δ epithelia (data not shown). Combined these data
indicate that cellular proliferation within the bladder epithelium and
bladder neck are not altered by the absence of KLF5 and suggest that
within the bladder neck epithelium cyclin D1 expression is not
dependent upon KLF5.Inhibition of urothelial maturation after deletion of Klf5
mRNA microarray analysis was performed on cDNA from whole
bladder total RNA isolated from E14.5 Klf5Δ/Δ and Klf5wt/wtShhGfpCre
+embryos. Of the 363 genes differentially expressed≥1.5 fold with a
p≤ .05, GO analysis identiﬁed two major subgroupings, epithelial cell
development/differentiation (GO:007398, GO:0030855, GO:0060429
GO:0008544) and cell adhesion (GO:0016337 and GO:0022610). As
early as E14.5, Klf5Δ/Δ tissue expressed reduced levels of urothelial
terminal differentiation markers including Upk1a, Upk1b, Upk3a, Ivl,
Sprr1a, Sprr2a, Krt8, Krt4, Krt18, Krt7, Cldn8, Cldn4, Cldn7, and Emp1
(Table 1) (Acharya et al., 2004; Erman et al., 2006; Smith et al., 2002;
Wu et al., 2009). These observations are consistent with our previous
developmental proﬁling of the urothelium that indicated that
expression of many terminal differentiation markers was initiated
as early as E13.5 (www.GUDMAP.org). As indicated in Table 1, a
number of genes previously identiﬁed as KLF5 targets following over
expression in ES cells were oppositely affected by deletion of Klf5 in
maturing bladder epithelial cells.KLF5 deﬁciency alters the expression of transcription factors associated
with urothelial maturation
Decreased expression of only 11 transcription factors was
observed after deletion of Klf5: Ehf (−3.46, pb .0044), Pparγ
(−3.33, pb .0011), Elf3 (−2.85, pb .00026), Grhl3 (−2.56, pb .0018),
Msx2 (−2.2 pb .0003), Foxq1 (−2.19, pb .0041), Foxa1 (−1.85,
pb .022), Zfp750 (−1.77, pb .00067), Ovol1 (−1.62, pb .00082), Elf5
(−1.6, pb .031), and Tcfap2c (−1.53, pb .0099). Three of these genes
were previously implicated in urothelial terminal differentiation:
Pparγ (peroxisome proliferator-activated receptor γ), Grhl3 (grainy-
head-like 3) and FoxA1 (Varley et al., 2009; Yu et al., 2009).
Quantitative real-time PCR of E14.5 whole bladder cDNA conﬁrmed
reductions in Klf5, Pparγ, Grhl3, Elf3, and Ovol1 expression (Fig. 5A).
Although p63 staining was decreased at E16.5, p63 mRNA levels were
not altered at E14.5. Taken together, deletion of Klf5 in the bladder
urothelium arrested urothelial maturation as early as E14.5.KLF5 regulation of Grhl3 in vitro
Since the defect observed in urothelial maturation in Grhl3−/−
fetuses was less severe than that observed in the Klf5Δ/Δ embryos, we
postulated that Grhl3 is a downstream target of KLF5 (Yu et al., 2009).
We created the reporter construct GL4mGrhl3Luc containing 1.7 kb of
the mouse Grhl3 promoter driving luciferase gene expression.
MatInspector analysis of the mGrhl3 promoter identiﬁed 8 putative
KLF binding sites located between −1250 and −1 (Cartharius et al.,
2005). GL4mGrhl3Luc was active in T24 bladder and HEK293T cells
(Figs. 5B, C). Co-transfection of the Klf5 expression construct, pKlf5,
induced GL4mGrhl3Luc activity in HEK293T cells while co-transfection
into T24 cells did not potentiate activity of the mGrhl3 promoter,
perhaps related to the high levels of endogenous KLF5 in these cells.
Co-transfection of Klf5 siRNA into T24 cells reduced GL4mGrhl3Luc
activity (p≤ .00467) that was accompanied by a reduction in the
levels of KLF5 (Fig. 5D). The decrease in Grhl3 mRNA seen in Klf5Δ/Δ
bladders in vivo coupled with these in vitro data support the concept
that Grhl3 is a downstream target of KLF5.
Fig. 4. KLF5 is required for maturation of the bladder urothelium. Immunohistochemical staining of control (A,C,E) and Klf5Δ/Δ (B,D,F) E18.5 fetuses with the antibodies indicated.
UPK1B, KRT20, and KRT14 are not expressed by the single layered epithelium lining the Klf5Δ/Δ bladder. Insets in E and F are higher magniﬁcation images of bladder urothelium. Note
the normal maturation of bladder neck and urethra that are also Klf5 deﬁcient. The muscle wall is abnormally thin in the Klf5Δ/Δ bladder (F). Scale bar in D represents 10 μm for A–D.
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The profound effect of Klf5 deﬁciency on maturation of the
urothelium was accompanied by alterations in development of the
surrounding mesenchyme that forms the smooth muscle and stromal
layers of the bladder. The musculature of the bladder wall wasfrequently thinner in Klf5Δ/Δ fetuses compared to controls (Figs. 1C vs
F, 3C vs D, 4E vs F, 6A-D). A prominent layer of cells was seen in all
E18.5 Klf5Δ/Δ fetuses that stained positively for αSMA and desmin
subjacent to the luminal epithelium that was absent or represented by
a few cells in the controls (Klf5ﬂox/ﬂoxShhGfpCre- and Klf5ﬂox/+ShhGfpCre+)
(Figs. 6A vs B, data not shown). The ectopic αSMA positive layer of
Table 1






Accession Effect of Klf5 over-
expression in ES cells1
Sprr1a −20.20 0.0004 NM_009264
Sprr2a −3.64 0.0004 NM_011468
Krt4 −3.19 0.0084 NM_008475
Krt8 −3.38 0.0001 NM_031170
Krt18 −2.84 0.0003 NM_010664
Krt15 −2.60 0.0002 NM_008469
Krt7 −2.81 0.0002 NM_033073
Upk3A −3.66 0.0011 NM_023478
Upk1A −6.44 0.0003 NM_026815
Upk1b −5.04 0.0002 NM_178924
Upk2 −8.79 .00004 NM_009476
Rab27b −3.60 .00073 NM_001082553
Ivl −3.76 0.0006 NM_008412
Cldn4 −2.13 0.0069 NM_009903
Tgm1 −1.74 0.0009 NM_019984
Snx31 −5.53 0.0011 NM_025712
Fmo5 −1.89 0.0023 NM_010232
Tmprss13 −2.43 0.0001 NM_001013373
Adh1 −5.846 0.0046 NM_007409
Klf5 −1.50 0.0073 NM_009769
Grhl3 −2.56 0.0018 NM_001013756
Pparγ −3.33 0.0011 NM_011146
2310045A20Rik 1.94 0.0313 NM_172710 Repressed
Ankrd1 1.65 0.0215 NM_013468 Repressed
Ap1m2 −2.02 0.0012 NM_001110300 Activated
Emp1 −1.54 0.0121 NM_010128 Activated
Foxa1 −1.85 0.0222 NM_008259 Repressed
Igfbp7 −1.95 0.0023 NM_008048 Repressed
Lamc2 −1.78 0.0050 NM_008485 Activated
Lrrn1 2.84 0.0301 NM_008516 Repressed
Ntn1 −1.53 0.0202 NM_008744 Repressed
Perp −2.15 0.0002 NM_022032 Activated
1600029D21Rik −6.25 0.0003 NM_029639 Activated
AA409316 −2.20 0.0052 NM_134087 Activated
Sfn −2.15 0.0003 XR_034292 Activated
1 As reported in Parisi et al. (2010) BMC Biology 8:128.
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Smoothelin staining was only detected in the detrusor muscle of
control and Klf5Δ/Δ E18.5 fetuses, indicating that the ectopic αSMA
staining population of cells was not likely mature smooth muscle
(Figs. 6C vs D).
Maturation of the bladder musculature is inﬂuenced by SHH
signaling from the epithelium to the subjacent mesenchyme (Tasian
et al., 2010). At E14.5 no alterations in the expression of αSMA, serum
response factor, Shh, or any of the SHH downstream targets Ptch1, Gli1,
Gli2, or Bmp4 implicated in formation of the detrusor were detected in
the mRNA microarray analysis or by RT-qPCR of E14.5 and E16.5
whole bladders. At both developmental time points, the levels of
expression of the components of the SHH signaling pathway were
highly variable in both control and Klf5Δ/Δ tissues consistent with the
dynamic regulation of SHH signaling during this window of
development (Fig. 6E) (Tasian et al., 2010). Such variability was not
seen in the same samples when RT-qPCR was performed in the
transcription factor analysis (Fig. 5A, data not shown). These
observations indicate that formation of the ectopic α-SMA positive
cell layer is not likely attributable to alterations in known components
of the SHH signaling pathway and is perhaps dependent on the
alteration of other urothelium derived signals.
Discussion
Klf5 deﬁciency in the developing bladder urothelium provides a
unique model of congenital functional obstructive uropathy present-
ing with the prenatal occurrence of VUR, hydroureter, and hydrone-
phrosis. In contrast to other mouse models, hydroureter andhydronephrosis seen after deletion of Klf5 were related to epithelial
differentiation or morphogenetic abnormalities in the bladder rather
than to physical obstruction, altered peristalsis or defects in ureteric
budding resulting in VUR due to inappropriate positioning of the
ureters into the bladder wall (Airik et al., 2006, 2010; Chang et al.,
2004; Iizuka-Kogo et al., 2007; Murawski et al., 2007; Nie et al., 2010).
Since Klf5 expression was maintained in the developing kidney and
ureter in the present model, we propose that VUR, hydroureters, and
hydronephrosis are likely secondary consequences of bladder dys-
morphogenesis. Serial sectioning of Klf5Δ/Δ E18.5 fetuses indicated
that the bladders of many fetuses were distended and the smooth
muscle layer was thin when compared to controls. These ﬁndings are
similar to those in the human syndromes megacystis-microcolon-
intestinal hypoperistalsis (OMIM 249210) and Eagle-Barrett (Denes
et al., 2004) also characterized by bladder distention, hydroureters,
and hydronephrosis at birth but for which genetic causes have not
been identiﬁed. Megacystis followed by hydroureter and hydrone-
phrosis is also observed in the Megabladder (Mgb) mouse (Ingraham
et al., 2010; Singh et al., 2007). Although the gene responsible for the
Mgb phenotype has not been identiﬁed, the urothelium is normal and
the primary defect is thought to be intrinsic to the maturing smooth
muscle progenitor cells of the developing bladder. A known regulator
of bladder smooth muscle maturation is SHH signaling from the epi-
thelium to the underlying mesenchyme (Tasian et al., 2010). Shh−/−
and Gli2−/− fetuses exhibit bladder hypoplasia (Haraguchi et al.,
2007). Like Klf5Δ/Δ fetuses, Gli2−/− fetuses also possess an ectopic
αSMA positive cell layer subjacent to the bladder epithelium whose
formation was attributed to a reduction in Bmp4 expression by the
mesenchyme (Cheng et al., 2008). Our examination of Shh, Ptc1, Gli2,
Gli1 and Bmp4 mRNAs indicated that SHH signaling from the
urothelium to the PTC1 receptor in the mesenchyme was likely not
altered in the Klf5Δ/Δ bladder, suggesting that other KLF5-dependent
signals made by the maturing urothelium mediate normal radial
patterning of the bladder mesenchyme. Prior studies in rats,
demonstrated that at postnatal day 10 an α-SMA, desmin, vimentin,
and vinculin positive cell layer was ﬁrst detected subjacent to the
urothelium (Baskin et al., 1996). In the adult human bladder,
suburothelial cells that express α-SMA, desmin, and vimentin but
not smoothelin are referred to as muscularis mucosa (Council and
Hameed, 2009). In humans and guinea pigs the suburothelial cells
termed myoﬁbroblasts/interstitial cells of the bladder are character-
ized by their expression of α-SMA, desmin, vimentin, c-kit, and Cx43
and are currently thought to relay signals from the urothelium to the
detrusor (Drake et al., 2006; Fry et al., 2007; McCloskey, 2010). In the
present study, the absence of staining for smoothelin in the
suburothelial region suggests that the α-SMA positive layer of cells
observed in Klf5Δ/Δ fetuses at E18.5 may represent precocious
formation of the interstitial cells of the lamina propria that may
contribute to fetal bladder dysfunction in the present model.
Abnormalities in urothelial maturation have been reported in only
a few mouse models. Upk3a and UpkII are expressed exclusively by
urothelial cells during advanced stages of differentiation. The ureteric
urothelium becomes thickened leading to occlusion and VUR in adult
mice lacking the uroplakins (Hu et al., 2000; Kong et al., 2004).
Formation of a multilayered urothelium is dependent on FGF7
signaling from the mesenchyme to the overlying epithelium (Tash
et al., 2001). The intermediate cell layer is absent and basal and
umbrella cells are intermixed within the single cell layered urothe-
lium of Fgf7−/− mice; in contrast to the single layered epithelium
observed in Klf5Δ/Δ fetuses that lacked terminally differentiated basal
and umbrella cells. The mRNA microarray analysis of E14.5 Klf5-
deﬁcient bladders did not detect alterations in expression of Fgf7 or its
receptor, Fgfr2 (Finch et al., 1995). In the absence of p63 a single
urothelial cell layer expressing Upks forms. Although p63 is expressed
by basal cells that give rise to the intermediate and umbrella cells, p63
expression is not a prerequisite for maturation of umbrella-like cells
Fig. 5. Candidate transcriptional targets of KLF5. (A) Normalized RT-qPCR gene expression of whole bladder cDNAs at E14.5. Asterisks indicate statistically signiﬁcant differences by
Student t-test (p≤0.05). (B) Regulation of pGL4mGrhl3Luc by KLF5 in HEK293T cells. (C) T24 cells transfected with Klf5 siRNA exhibited diminished pGL4mGrhl3Luc activity. (D)
Western blot analysis of cell lysates from T24 cells transfected with the indicated SiRNA for the presence of KLF5.
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in Klf5Δ/Δ urothelium does not explain the failure of terminal
differentiation. The absence of p63, KRT5, and KRT14 expression in
the single layer of cells lining the Klf5Δ/Δ bladder suggests these cells
are not basal cells. The persistent uniform expression of FOXA1, and
the lack of expression of terminal differentiation markers of basal,
intermediate, and umbrella cells indicates that in the absence of KLF5,
urothelial precursor cells remain in an undifferentiated state.
Little is known of the transcriptional hierarchy regulating
urothelial maturation. Pparγ, Grhl3, Ovol1, Foxa1, Elf3 and Ehf are
coordinately expressed with Klf5 in the developing bladder and other
embryonic epithelial tissues (http//:genepaint.org) (Auden et al.,
2006; Feldman et al., 2003; Li et al., 2006; Oettgen et al., 1997). We
have determined that KLF5 regulates transcription of the Grhl3 gene in
vitro. Although several putative “KLF” binding sites were identiﬁed by
MatInspector analysis (Cartharius et al., 2005), three distinct KLF5
consensus binding sites were recently proposed based on genes
commonly identiﬁed in samples subjected to CHIP Seq and mRNA
Microarray analysis (Parisi et al., 2010). An examination of 1.7 kb of
themGrhl3 promoter with these sequences identiﬁed 7 putative KLF5
binding sites. Thus Grhl3 may be a direct downstream target of KLF5
during urothelial maturation. Consistent with this concept, Grhl3−/−
fetuses form a stratiﬁed urothelium with a defect in formation of the
terminally differentiated umbrella cells (Yu et al., 2009). Transgluta-
minase I (Tgm1), a key enzyme in epithelial barrier formation, and
UpkII are direct downstream targets of GRHL3 (Ting et al., 2005; Yu et
al., 2009). In addition to Tgm1 and UpkII, previous studies indicated
that the expression of Sprr1a, Snx31, Fmo5, Tmprss13, and Adh1
normally increase during the course of bladder maturation. The
expression of all of these genes was down regulated in both E14.5
Klf5Δ/Δ and in E18.5 Grhl3−/− bladders (Table 1)(Yu et al., 2009).
Several lines of evidence also suggest that Pparγ plays a critical role
in regulating urothelial maturation. Pparγ expression increases as themouse urotheliummatures (Jain et al., 1998) and PPARγ activation by
the agonist troglitazone induced expression of the terminal differen-
tiation markers, Upks la, 1b, II and IIIa, Krt13, Krt20 and Cldn3 in
cultured human urothelial cells (Varley et al., 2004, 2006, 2009). In
committed urothelial cells, PPARγ induced FoxA1 and Irf1 that directly
interacted with cis –regulatory elements in the Upk1a, 2, and 3a gene
promoters (Varley et al., 2009). In the differentiated E18.5 urothelium,
FOXA1 was expressed at the highest levels in the umbrella cell layer
suggesting that this signaling paradigm occurs during initial matura-
tion of the mouse urothelium. By E14.5, a dramatic reduction in Pparγ
expression occurred in Klf5Δ/Δ bladders accompanied by greater
reductions in the expression of Upk1a, 2, and 3a and the absence of
terminally differentiated urothelial cells. KLF5 directly regulates Pparγ
expression during the differentiation of adipocytes (Oishi et al., 2005).
The present observations suggest that KLF5 may also regulate Pparγ
during the process of urothelial maturation.
Developmental roles for Elf3 and Ovol1 in maturation of the
bladder have not been previously proposed. Prior studies of Elf3
deﬁcient mice revealed that ELF3 is required for normal development
of the intestinal epithelium (Ng et al., 2002), morphogenesis of the
urothelium was not evaluated. Elf3 expression was dramatically
increased in adult urothelium in response to infection and has been
shown to directly regulate claudin 7 expression (Mysorekar et al.,
2002), Kohno et al., 2006). In the dermis, Ovol1 is required for
committed epidermal progenitor cells to exit from proliferation (Nair
et al., 2006). Ovol1-deﬁcient mice are unable to properly form the skin
barrier and develop cystic kidneys (Teng et al., 2007). A Kruppel-like
binding site was previously identiﬁed at position −167 within the
mOvol1 promoter (Li et al., 2002). Further study of the regulatory
mechanisms controlling the expression of these genes will provide
new insights into the urothelial differentiation program and provide
new paradigms for understanding differentiation and perhaps repair
in other epithelial tissues.
Fig. 6. KLF5 is required for normal formation of the bladder mesenchyme. (A–D)
Immunohistochemical analysis of E18.5 fetuses for α-smooth muscle actin and
smoothelin reveals both markers are expressed by the detrusor muscle (dm). Klf5Δ/Δ
fetuses possess an ectopic α-SMA positive (arrow in B), smoothelin negative
(arrowhead in D) region subjacent to the bladder epithelium/urothelium (u) as
indicated at higher magniﬁcation in insets (A, B). Green arrowhead in (C) indicates
thick lateral detrusor muscle compared to diminished bladder wall thickness, green
arrowhead in (D). (E) Normalized RT-qPCR gene expression of E14.5 and E16.5 whole
bladders suggests SHH signaling is not disrupted in Klf5Δ/Δ bladders. Bars indicate s.e.m.
between individual samples (E14.5 n=3, E16.5 n=5). No statistically signiﬁcant
differences were observed (pb .05).
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by KLF5 (Bateman et al., 2004; Nandan et al., 2004, 2005). Cyclin D1
was increased in bladder cancer cells over expressing KLF5 that
showed an increase in the rate of proliferation (Chen et al., 2006). In
the present study, changes in the proliferation rate in the bladder
urothelium were not noted between controls and Klf5Δ/Δ mice. We
also observed that between E14.5 and E16.5, cyclin D1 proteinwas not
detectable in the normal urothelium indicating that proliferation is
not dependent on KLF5 or cyclin D1 during this period of
development. In contrast to the bladder urothelium, epithelial cells
within the fetal bladder neck were proliferative and expressed cyclin
D1 even in the absence of KLF5. KLF5 deﬁcient embryonic stem cells
(ESC) exhibit a decreased rate of cellular proliferation associated with
altered regulation of the cyclin-dependent kinase inhibitor, p21, and
the Akt co-activator Tcl1 (Ema et al., 2008). Alterations in these genes
were also not observed in the microarray analysis of mRNA isolated
from E14.5 whole bladders. In ESC, KLF5 deﬁciency can be compen-
sated for by KLF2 and KLF4 (Ema et al., 2008; Jiang et al., 2008; Nandan
and Yang, 2009). Compensation by KLF2 or KLF4 is unlikely in the
Klf5Δ/Δ bladder epithelium since Klf4mRNA expression was restricted
to the bladder mesenchyme and Klf2 expression was not detectable
(http://www.genepaint.org).
The present ﬁndings support the concept that activities of KLF5 are
highly dependent on developmental context, being critical for
embryonic urothelial maturation rather than maintenance of prolif-
eration. These studies demonstrate a novel role for KLF5 as a critical
regulator of urothelial maturation during late embryonic develop-
ment. We propose that Pparγ and Grhl3 may participate in a KLF5
dependent gene network regulating maturation of the urothelium.Acknowledgments
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